In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 27, no. 2, p. 198-201
|
In: Langenbeck's Archives of Surgery, 2015, vol. 400, no. 6, p. 675-682
|
In: Interactive CardioVascular and Thoracic Surgery, 2017, vol. 24, no. 5, p. 740-746
|
In: European Archives of Oto-Rhino-Laryngology, 2015, vol. 272, no. 7, p. 1725-1731
|
In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 26, no. 4, p. 545-550
|
In: World Journal of Surgery, 2015, vol. 39, no. 10, p. 2529-2534
|
In: Strahlentherapie und Onkologie, 2015, vol. 191, no. 12, p. 988-990
|
In: Annals of Surgical Oncology, 2015, vol. 22, p. 959-963
|
In: Scientific Reports, 2020, vol. 10, no. 1, p. 7078
Immunotherapies, such as checkpoint blockade of programmed cell death protein-1 (PD-1), have resulted in unprecedented improvements in survival for patients with lung cancer. Nonetheless, not all patients benefit equally and many issues remain unresolved, including the mechanisms of action and the possible effector function of immune cells from non-lymphoid lineages. The purpose of this...
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, no. 8, p. 1563-1573
|